Edition:
United States

People: Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

3,028.50INR
1:30am EDT
Change (% chg)

Rs-294.35 (-8.86%)
Prev Close
Rs3,322.85
Open
Rs3,030.00
Day's High
Rs3,070.00
Day's Low
Rs2,995.00
Volume
215,088
Avg. Vol
32,602
52-wk High
Rs4,382.95
52-wk Low
Rs2,750.00

Vohra, Umang 

Mr. Umang Vohra is Executive Vice President, Head - North America Generics of Dr. Reddy's Laboratories Ltd since January 2013. He resigned as Chief Financial Officer of the company effective January 2, 2013. He has over 14 years of experience across various functions within finance, strategic planning and corporate development. He is responsible for managing Company's organization’s global finance functions including among others Accounts and Controlling, Taxation, Compliance, Secretarial, Investor Relations and Treasury. He joined the Company in 2002, initially working as Deputy Chief Financial Officer, and has been part of several of Company's key initiatives like acquisitions, research and development, de-risking transactions, and operational improvements and migration to IFRS in Company's accounting, governance and finance processes. Prior to joining the Company, Mr. Vohra worked with Eicher and PepsiCo India. Mr. Vohra has a base degree in computer engineering and he holds an MBA with a specialization in Finance from TA Pai Institute of Management (TAPMI), India.

Basic Compensation

Total Annual Compensation, INR --
Restricted Stock Awards, INR --
Long-Term Incentive Plans, INR --
All Other, INR --
Fiscal Year Total, INR 5,500,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

114,639

G. Prasad

109,464,000

Saumen Chakraborty

15,000,000

Sripada Chandrasekhar

--

Abhijit Mukherjee

14,600,000

Amit Biswas

--
As Of  30 Mar 2014